JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target from $81 to $86.
Charles & Colvard Q1 EPS $0.03 Beats $0.02 Estimate, Sales $10.28M Beat $9.20M Estimate
Charles & Colvard (NASDAQ:CTHR) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 50 percent. This is unchanged from the same period last year. The company reported